According to the new market research report “Cell Line Development Market by Product (Equipment, Media and Reagents), by Source, by type, by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) – Analysis & Global Forecast to 2019“, published by MarketsandMarkets™, analyzes and studies the major market drivers, threats, opportunities, and challenges.
Don’t miss out on business opportunities in Cell Line Development Market. Speak to our analyst and gain crucial industry insights that will help your business grow: http://bit.ly/2PwTmjz
Early buyers will receive 10% customization on reports.
The cell line development market is highly competitive with a large number of players, including both big and small players, operating in this market. Cell lines are used in many pharmaceutical and biotechnology industries, academic research institutes, and diagnostic laboratories. In order to develop high-yielding and stable cell lines, companies and research institutes are engaged in research activities to develop more efficient technologies for development of cell lines.
The global market is segmented on the basis of product, source, type, application, and geography. The global market, by product is categorized into equipment and media and reagents. The media and reagents segment is further divided into serum, media, and reagents. The reagents market is expected to account for the largest share of the market. However, media is expected to be the fastest-growing segment in the reagents market.
The cell line development market, by type is divided into primary cell lines, continuous cell lines, hybridomas, and recombinant cell lines. Recombinant cell lines accounted for the largest share of the market, by type. However, the primary cell lines segment is expected to grow at the fastest rate in the market, by type.
Based on the source of cell lines, the market is segmented into mammalians, insects, and amphibians. The mammalian segment is the largest and the fastest growing segment of the market, by source.
On the basis of applications, the market is segmented into bioproduction, tissue engineering and regenerative medicine, toxicity testing, research, and drug discovery. In 2014, the bioproduction segment accounted for the largest share of the cell line development application market, as cell lines are extensively used in diagnostics, vaccine production, and manufacturing of recombinant protein therapeutics.
The key factors that are expected to spur this market are increased demand for monoclonal antibodies, rising vaccine production, and use of innovative technologies. However, developing stable and authentic cell lines poses a major challenge for this market. Some of the opportunities for cell line development market are low income countries and increasing risk of pandemics and communicable diseases.
On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia, and Rest of the World (RoW).
Browse and in-depth TOC on “Cell Line Development Market”
114 – Tables
64 – Figures
225 – Pages
View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/cell-line-development-market-152900899.html
The global cell line development market is expected to reach $3.96 billion by 2019 from $2.2 billion in 2014, and is expected to grow at a CAGR of 12.5% from 2014 to 2019. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America is expected to maintain its leadership position in the market in the coming years.
Some of the major players in the global market include American Type Culture Collection (ATCC) (U.S.), Lonza Group AG (Switzerland), Thermo Fisher Scientific, Inc. (U.S.), GE Healthcare (U.K.), Sigma Aldrich Corporation (U.S.), Selexis SA (Switzerland), European Collection of Cell Cultures (ECACC) (U.K.), Corning, Inc. (U.S.), Wuxi App Tec, Inc. (China), and Sartorious AG (Germany).
Request for Free Sample Report @ http://bit.ly/2QGjetl
Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/cell-line-development-market.asp
Visit Our Website: https://www.marketsandmarkets.com
